Investor Day Japan 2026 BioLabs Friends Present -Tell Us Your Biotech Story-

Japanese page

The Innovation Center of NanoMedicine (iCONM) in collaboration with BioLabs, Astellas Pharma Inc., Life Science Innovation Network Japan (LINK-J), and BioLabs Global (U.S.) will co-host Investor Day Japan 2026. This event brings together the BioLabs Friends in Japan and the global BioLabs network to provide a platform for early- to mid-stage drug discovery startups to share their stories with investors and industry experts from Japan and around the world. Through this event, we aim to help participating startups seize new business opportunities and accelerate the growth of their drug discovery ventures. 

In addition to startup pitch presentations, the program will feature two panel discussions focused on pharma collaboration and the growth of drug discovery startups. Panel 1 aims to explore how collaborations between drug discovery startups and pharmaceutical companies are formed. Pharma speakers will share their perspectives on what types of startups they are interested in partnering with, how projects are evaluated prior to clinical proof of concept, and what constitutes “science worth collaborating on” from a pharma perspective. Startup speakers will also draw on past collaboration experiences to highlight the key factors that led to successful deals. Panel 2 will focus on how scientifically distinctive ideas evolve into promising startups through various challenges, as well as the issues that growing startups face today. The discussion will examine the perspectives and lessons needed to translate research into viable businesses and drug discovery programs.

※This event is conducted as part of the TIB CATAPULT / LINK-BioBAY TOKYO initiative.